Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Trop Med Int Health ; 2(4): 319-24, 1997 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-9171839

RESUMO

Thirty-three children aged 6 months to 7 years from an area with multidrug-resistant Plasmodium falciparum strains were treated with 25 mg/kg body weight of mefloquine base as a single oral dose. They were followed-up using the modified 28-day WHO extended field test. The parasite isolates from these patients were cultured in vitro with different concentrations of mefloquine. All children were parasite-negative by day 4, and 31 remained so throughout the period of observation. Two patients who were parasitaemic on days 16 and 28 were successfully treated with a sulphadoxine/pyrimethamine combination. Parasitological and clinical responses were well correlated. The mean parasite clearance time was 65 +/- 10.2 hours. A mefloquine concentration of 64 pmol/well inhibited schizont growth and the EC50 and EC99 were 5.5 and 5.4 pmol/well (1.1 and 10.8 mumol/l blood) respectively. This indicates reduced parasite susceptibility to the drug in vitro.


Assuntos
Antimaláricos/uso terapêutico , Malária Falciparum/tratamento farmacológico , Mefloquina/uso terapêutico , Animais , Anti-Infecciosos/uso terapêutico , Antimaláricos/administração & dosagem , Antimaláricos/farmacologia , Criança , Pré-Escolar , Resistência Microbiana a Medicamentos , Resistência a Múltiplos Medicamentos , Quimioterapia Combinada , Feminino , Humanos , Lactente , Masculino , Mefloquina/administração & dosagem , Mefloquina/farmacologia , Testes de Sensibilidade Microbiana , Nigéria , Parasitemia/diagnóstico , Parasitemia/tratamento farmacológico , Plasmodium falciparum/efeitos dos fármacos , Pirimetamina/uso terapêutico , Sulfadoxina/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...